RedHill Biopharma (NASDAQ:RDHL) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of RedHill Biopharma (NASDAQ:RDHL – Free Report) in a research note issued to investors on Wednesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. RedHill Biopharma Price Performance RDHL opened at $2.07 on Wednesday. The business’s 50-day moving average price is $2.63 and its two-hundred day […]
